Increased isobutanol production in Saccharomyces cerevisiae by eliminating competing pathways and resolving cofactor imbalance

Microbial Cell Factories
2013.0

Abstract

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Isobutanol is an important target for biorefinery research as a next-generation biofuel and a building block for commodity chemical production. Metabolically engineered microbial strains to produce isobutanol have been successfully developed by introducing the Ehrlich pathway into bacterial hosts. Isobutanol-producing baker’s yeast (<jats:italic>Saccharomyces cerevisiae</jats:italic>) strains have been developed following the strategy with respect to its advantageous characteristics for cost-effective isobutanol production. However, the isobutanol yields and titers attained by the developed strains need to be further improved through engineering of <jats:italic>S. cerevisiae</jats:italic> metabolism. </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Two strategies including eliminating competing pathways and resolving the cofactor imbalance were applied to improve isobutanol production in <jats:italic>S. cerevisiae</jats:italic>. Isobutanol production levels were increased in strains lacking genes encoding members of the pyruvate dehydrogenase complex such as <jats:italic>LPD1</jats:italic>, indicating that the pyruvate supply for isobutanol biosynthesis is competing with acetyl-CoA biosynthesis in mitochondria. Isobutanol production was increased by overexpression of enzymes responsible for transhydrogenase-like shunts such as pyruvate carboxylase, malate dehydrogenase, and malic enzyme. The integration of a single gene deletion <jats:italic>lpd1</jats:italic> Δ and the activation of the transhydrogenase-like shunt further increased isobutanol levels. In a batch fermentation test at the 50-mL scale from 100 g/L glucose using the two integrated strains, the isobutanol titer reached 1.62 ± 0.11 g/L and 1.61 ± 0.03 g/L at 24 h after the start of fermentation, which corresponds to the yield at 0.016 ± 0.001 g/g glucose consumed and 0.016 ± 0.0003 g/g glucose consumed, respectively. </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>These results demonstrate that downregulation of competing pathways and metabolic functions for resolving the cofactor imbalance are promising strategies to construct <jats:italic>S. cerevisiae</jats:italic> strains that effectively produce isobutanol. </jats:sec>

Knowledge Graph

Similar Paper

Increased isobutanol production in Saccharomyces cerevisiae by eliminating competing pathways and resolving cofactor imbalance
Microbial Cell Factories 2013.0
Metabolic engineering of <i>Escherichia coli</i> W for isobutanol production on chemically defined medium and cheese whey as alternative raw material
Journal of Industrial Microbiology and Biotechnology 2020.0
Increase ethyl acetate production in <i>Saccharomyces cerevisiae</i> by genetic engineering of ethyl acetate metabolic pathway
Journal of Industrial Microbiology and Biotechnology 2019.0
Enhanced isoprenoid production <scp>f</scp>rom xylose by engineered <i>Saccharomyces cerevisiae</i>
Biotechnology and Bioengineering 2017.0
Metabolic engineering of yeast for fermentative production of flavonoids
Bioresource Technology 2017.0
Biotechnological production of 1,2,4-butanetriol: An efficient process to synthesize energetic material precursor from renewable biomass
Scientific Reports 2015.0
Optimal cofactor swapping can increase the theoretical yield for chemical production in Escherichia coli and Saccharomyces cerevisiae
Metabolic Engineering 2014.0
Optimal cofactor swapping can increase the theoretical yield for chemical production in Escherichia coli and Saccharomyces cerevisiae
Metabolic Engineering 2014.0
Reconstruction of metabolic module with improved promoter strength increases the productivity of 2-phenylethanol in Saccharomyces cerevisiae
Microbial Cell Factories 2018.0
Efficient Production of Pyruvate Using Metabolically Engineered Lactococcus lactis
Frontiers in Bioengineering and Biotechnology 2021.0